Generated by GPT-5-mini| Sackler family | |
|---|---|
![]() | |
| Name | Sackler family |
| Origin | United States |
| Founded | Early 20th century |
| Notable | Arthur Sackler; Raymond Sackler; Mortimer Sackler; Richard Sackler; Purdue Pharma |
Sackler family The Sackler family is an American family known for roles in pharmaceuticals, philanthropy, and controversies surrounding opioid analgesics and public philanthropy. Members became prominent through medical publishing, pharmaceutical commerce, and the ownership and management of a pharmaceutical company associated with opioid marketing; their activities have led to extensive legal, cultural, and institutional responses.
The family traces roots to immigrants who settled in New York and pursued careers in medicine and business, including involvement with medical publishing and advertising that connected to institutions like American Medical Association, Johns Hopkins Hospital, Massachusetts General Hospital, Columbia University, and New York University. Early figures established enterprises intersecting with medical journals, pharmaceutical advertising, and patent medicines, linking to entities such as Rudolph Sackler-era businesses, the NewYork-Presbyterian Hospital, the Royal College of Physicians, and commercial partners in London, Paris, and Tel Aviv. Their activities intersected with publications and societies including the New England Journal of Medicine, Lancet, British Medical Journal, Medical Advertising Bureau, and medical associations in Illinois, Pennsylvania, and California.
Family members invested in and led a pharmaceutical company that developed a proprietary opioid analgesic, marketed under a brand that became central to an epidemic of opioid misuse and overdose in the United States. The company implemented national sales strategies involving drug formularies, managed care organizations, and pharmaceutical sales forces interacting with entities such as Food and Drug Administration, Centers for Disease Control and Prevention, Drug Enforcement Administration, American Pain Society, and hospital systems including Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Mayo Clinic, and UCLA Health. Marketing campaigns targeted prescribers connected to medical societies like the American Academy of Pain Medicine and institutions such as Veterans Health Administration, Kaiser Permanente, and private practices across Ohio, West Virginia, Kentucky, Pennsylvania, and Massachusetts.
Legal responses involved a complex web of civil litigation, federal investigations, state lawsuits, and regulatory actions against the company and individual family members; these actions engaged courts and agencies such as the United States Department of Justice, the Supreme Court of the United States in related jurisprudence, numerous state attorneys general (including New York Attorney General), and bankruptcy proceedings in Bankruptcy Court. Major settlements and rulings connected to municipal and county plaintiffs (for example, cities in Ohio, counties in Kentucky, municipalities in Massachusetts), healthcare insurers like Blue Cross Blue Shield, and tribal governments resulted in multi-party negotiations involving trust structures, releases reviewed by the Second Circuit Court of Appeals, and oversight proposals referencing laws such as the Controlled Substances Act. Criminal pleas and deferred prosecution agreements implicated executives and corporate entities, with matters considered by the United States Attorney's Office and subject to appellate practice in the United States Court of Appeals for the Second Circuit.
Family philanthropy included donations to cultural, academic, and medical institutions that led to named galleries, schools, wings, and endowed chairs at organizations such as the Metropolitan Museum of Art, British Museum, Guggenheim Museum, Harvard University, Yale University, Princeton University, Oxford University, Cambridge University, National Gallery of Art, Solomon R. Guggenheim Museum, Royal Academy of Arts, Tel Aviv University, Weizmann Institute of Science, and the Whitney Museum of American Art. Following public scrutiny, some institutions debated, removed, or retained naming, involving governance bodies like university boards of trustees and museum directors, and invoking policies on donor recognition, reputational risk, and board resolutions used by entities such as Smithsonian Institution, Carnegie Corporation of New York, and municipal cultural commissions.
Key figures include siblings and descendants who pursued careers in medicine, business, and philanthropy, with roles tied to companies and institutions such as Purdue Pharma, Ikaria, Arthur Sackler Gallery-adjacent donors, and medical centers bearing family names. Notable individuals associated by public record and litigation include physicians, executives, and trustees who interacted with organizations including the American Medical Association, Royal Free Hospital, Mount Sinai Health System, Cedars-Sinai Medical Center, Barnard College, Tufts University, and professional associations like the American College of Surgeons and American Academy of Pediatrics.
The family's prominence and controversies generated extensive media coverage, documentaries, investigative reporting, and dramatizations appearing in outlets and works such as The New York Times, The Washington Post, The Wall Street Journal, The Guardian, ProPublica, television documentaries on PBS, series on Netflix, investigative books published by major presses, and feature films screened at festivals like Sundance Film Festival and discussed in cultural forums including the Paley Center for Media and SXSW. Coverage prompted public debates involving elected officials, legislative hearings in bodies such as the United States Congress and state legislatures, and cultural institutions revising donor policies in response to activist campaigns and petitions organized by civic groups in cities like New York City, London, Los Angeles, Boston, and Chicago.
Category:American families Category:Philanthropy controversies Category:Pharmaceutical industry